As a part of a global initiative, SERDIA Pharmaceuticals has launched a comprehensive programme in India called as ‘Angina Awareness India’. With this programme, Serdia, a leader in cardiology, has rolled out a nationwide campaign to raise awareness on angina. The campaign urged people to not ignore symptoms of angina-like clutching pain, heaviness or tightness in the chest, pain in neck/shoulder, fatigue, backache and breathlessness and to consult a doctor at an early stage. The field force also reached out to thousands of doctors through their in-clinic awareness drive.
Angina is often the initial manifestation of coronary artery disease (CAD), the most frequent cause of death worldwide today, and has been shown to double the risk of major cardiovascular diseases. Approximately one-third of the outpatients with chronic CAD suffer from angina, while 30% of patients continues to experience angina symptoms as early as one month after revascularisation.